Details

Last Funding Type

Series Unknown

Industries

Biotechnology,Chemical,Renewable Energy

Founded date

Jan 1, 2013

Number Of Employee

1 - 10

Operating Status

Active

Pareto Biotechnologies has pioneered development of a revolutionary synthetic biology platform that produces naturally derived, high value “designer molecules.”
Pareto’s technology is the result of over a decade of academic and private sector research and intellectual property focused on one particular polyketide pathway. Building on Dr. Joe Noel’s groundbreaking research at the Salk Institute, this pathway – previously dismissed as the “poor man’s pathway” – is the foundation of Pareto’s platform, capable of generating known products and novel molecules.